Supplementary Figure 1: Inhibition of the protease in the FRET-based enzyme activity assay at various concentrations of 1 and 2 in the same ratio as in the ligation assay. Supplementary Figure 2: The LC chromatogram of the ligation of 1 and 2 in different solvents and with or without enzyme present, clearly shows that multiple outcomes of the ligation process are possible and highly depend on the reaction conditions. Supplementary Figure 12: 1 H-and 13 C-NMR spectrum of 8 Supplementary Figure 29: RP-HPLC chromatogram of 21 Supplementary Figure 30: Deconvoluted ESI-MS spectrum of CVB3 3C Pro HPLC-ESI-MS spectra were recorded with an Agilent 1100 LC/MS system equipped with a Luna-C18, 3 µm by Phenomenex. A gradient of water (solvent A) and acetonitrile (solvent B) was used and each solvent contained 0.1% (vol/vol) formic acid. During the analysis the the solvent ratio (A:B) was changed from 95:5 to 1:99, while maintaining a flowrate of 1 ml/min. Mass spectrometry with 3C Pro -C147A mutant 20 µL of a 0.425 µg/ml enzyme solution (containing also 100 mM Tris*HCl, 200 mM NaCl, 4 mM EDTA, 20% glycerine) were incubated with 250 µM inhibitor for 60 minutes.
Chymotrypsin 2) Human factor Xa 3) Human Caspase-3 4) 14 > 500 µM > 500 µM > 500 µM > 500 µM 20 > 500 µM > 500 µM > 500 µM > 300 µM 1) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 57 µM tert. butyloxycarbonyl (Boc)-LGR-7-amino-4methylcoumarin (AMC) as substrate; 2) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 1.6 mM AF-AMC as substrate. 3) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 114 µM Boc-LGR-AMC as substrate; 4) in 50 mM HEPES-NaOH pH 7.5 / 100 mM NaCl / 1 mM EDTA / 0.1% (w/v) CHAPS / 10% (v/v) glycerol /2 mM DTT with 10 µM acetyl-DEVD-AMC as substrate;
Identity and purity (>95%) of all compounds were determined by chromatography (silica or RP-18 HPLC), by fully assigned 1 H-and 13 C NMR spectra (see supplementary NMR spectra) and by high-resolution mass spectra. Solvents were purchased in p.a. quality by VWR 
Purification with high performance liquid chromatography was performed with an Agilent 1260 Infinity Binary LC System equipped with a Nucleodur C18 HTec, 5 µm by Macherey Nagel (Düren, Germany). A gradient from water and acetonitrile (with 0.1% trifluoroacetic acid respectively) was utilized to separate the compounds.
Flash chromatography was performed with an Isolera One System from Biotage (Upsala, Sweden) using pre-packed KP-Sil SNAP-cartridges.
The electrophilic probe 1 has been synthesized according to the procedure of Marigo et al. 1
A mixture of 2-cyanoacetyl hydrazide (1.25 g, 12.7 mmol) and cycloheptanone (1.42 g, 12.7 mmol) was heated in ethanol (12 ml 
Ethyl (2S,3S)-epoxy-4-oxo-butanoate (50 mg, 0.34 mmol, 1 eq) was dissolved in 1,2dichloroethane (5 ml). After addition of 2 (50 mg, 0.25 mmol, 0.75 eq) in methanol (1 ml 
2 (1 eq) was dissolved in pyridine (10 ml per 0.5 mg 2) and stirred vigorously. Trans-2,3-Epoxysuccinic acid (2.95 eq) and N,N'-dicyclohexylcarbodiimide (2.95 eq) was added and the suspension stirred overnight. The solvent was removed in vacuo, the residue was taken up in ethanol and aqueous sodium hydroxide solution (2 mol/l, 2 eq) was added dropwise. After 30 minutes of stirring, the solvent was removed in vacuo, after which the residue was taken up in aqueous acetonitrile, filtered and purified with reversed phase liquid chromatography, which (2), 27.9 (2), 23,9 (2), 13.9; mp.: > 250°C (decomp.). 163.8, 160.5, 134,8, 84.8, 61.1, 56.4, 53.7, 52.4, 34.3, 34.2, 27.8 (2) , 23.9 (2), 13.9; mp.: 70-71°C.
Trans-epoxysuccinic acid (=2,3-epoxybutanediacid, 200 mg, 1. 128.4, 126.9, 126.4, 125.9, 123.9, 57.0, 53.5, 52.9, 40.9, 34.7 (2), 28.3 (2), 24.4 (2) two carbonyl atoms and C-4 could not be resolved. mp.: 141-142°C.
Ethyl (2E)-4-oxo-2-butenoate (62 µl, 0.5 mmol, 1 eq) was dissolved in methanol (15 ml).
After addition of 2 (100 mg, 0. 5 mmol, 0.1 eq) sodium cyanoborohydride (62 mg, 1 mmol, 2 eq) was added and the solution was stirred for twelve hours. The reaction was quenched with water, the solvent removed in vacuo and the residue was purified with reversed phase high performance liquid chromatography, yielding 7 as a white solid. 
2 (120 mg, 0.61 mmol, 1 eq) was dissolved in ice cooled acetic acid (5 ml (2), 29.1 (2), 25.1 (2).
70 µmol, 1 eq) was dissolved in 20 ml ethanol. Catalytic amounts of N,N-dimethylformamide were added and oxalylchloride (7.2 µl, 84 µmol, 1.2 eq) were added dropwise with vigorous stirring. The reaction mixture was stirred overnight after which the solvents were evaporated.
The residue was purified with reversed phase-high performance liquid chromatography, furnishing 9 as a colorless solid. 
5-Amino-1-phenyl-1.2-dihydropyrazol-3-one (175 mg, 1 mmol, 1 eq) was dissolved in 7 ml 1,4-dioxane and transferred to a microwave vessel (pressure stable, max. volume 10 ml).
Maleic anhydride (147 mg, 1.5 mmol, 1.5 eq) was added, the vessel was sealed with a septum and placed in an Initiator + microwave reactor from Biotage (Uppsala, Sweden 1, 165.5, 139.3, 129.6 (2), 129.4, 127.6, 127.4, 123.5 (2) , 93.7, 60.7, 14.1 2 carbonyle signals could not be resolved; mp.: > 220°C (decomp.)
2 (66 mg, 0.34 mmol, 1 eq) was dissolved in pyridine (3 ml) 1, 154.2, 147.1, 135.5, 133.1, 80.6, 61.8, 57.7, 35 .0 (2), 28.8 (2) 6, 164.2, 161.8, 135.6, 135.3, 128.3, 85.9, 61.5, 58.1, 35.6 (2) , 28.9 (2), 25.1 (2), 14.4; mp: 148-149°C.
Maleamic acid (1.61 g, 14 mmol, 1 eq) was djssolved in EtOH. Concentrated sulfuric acid (0.15 ml, 0.2 eq) was added and the mixture was refluxed for 2.5 h. After removal of the solvent the white precipitate was purified over silica by MPLC with ethyl acetate/n-hexane 12, 165.82, 132.86, 127.53, 60.08, 13.88; mp: 94 (2), 131.8 (2), 33.6 (2), 14.4 (2) .
Compound 2 (100 mg, 0.5 mmol, 1 eq) and benzotriazol- 
According to the synthetic procedure for 2, 5-Amino-1-(4-heptyl)-1,2-dihydropyrazol-3-one was prepared by the reaction of 4-heptanone and 2-cyanoacetyl hydrazide, which yielded the desired pyrazolone after reduction with sodium borohydride. 1, 73.3, 54.5, 36.3 (2) , 18.9 (2), 13.9 (2); mp.: > 208°C (decomp.).
5-Amino-1,2-dihydro-3H-pyrazol-3-one 3 (350 mg, 3.55 mmol, 1 eq) was dissolved in acetic acid (30 ml) and cooled with an ice bath. Maleic anhydride (765 mg, 7.8 mmol, 2.2 eq) was 5, 166.1, 165.3, 158.3, 131.3, 128.9, 60.3, 33.9, 13.8; mp.: 63-64°C 